Alaunos Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $8.3M
Liabilities Breakdown FY2023
Total Liabilities: $2.0M
Asset Breakdown
Total Assets: $8.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.1M | 73.4% |
| Accounts Receivable | $1.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.2M | 26.6% |
Liabilities Breakdown
Total Liabilities: $2.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $616.0K | 31.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.3M | 68.5% |